Efficacy of imidacloprid 10%/moxidectin 1% spot-on formulation (Advocate®) in the prevention and treatment of feline aelurostrongylosis

BACKGROUND: In three randomized, controlled laboratory efficacy studies, the efficacy in the prevention of patent infections of a topical combination of imidacloprid 10%/moxidectin 1% (Advocate® spot-on formulation for cats, Bayer Animal Health GmbH) against larval stages and immature adults of Aelu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Parasit Vectors
Main Authors: Heuer, Lea, Petry, Gabriele, Pollmeier, Matthias, Schaper, Roland, Deuster, Katrin, Schmidt, Holger, Blazejak, Katrin, Strube, Christina, Di Cesare, Angela, Traversa, Donato, Schnyder, Manuela, McKay-Demeler, Janina, von Samson-Himmelstjerna, Georg, Mangold-Gehring, Sandra, Böhm, Claudia
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7017503/
https://ncbi.nlm.nih.gov/pubmed/32051008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13071-020-3937-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados